Sanofi Said to Weigh Higher Takeover Bid for Genzyme

Sanofi-Aventis SA is weighing whether to make a sweetened takeover offer for Genzyme Corp. as soon as next week, said people with knowledge of the matter.

France’s largest drugmaker is leaning toward raising the current $69-a-share offer by $1 or $2, said two of the people, who declined to be identified because the plans are private. Sanofi executives and top advisers will meet later this week to discuss how to proceed and a final decision hasn’t been made, one person said.